ℹ️
🇬🇧
Search
Search for publications relevant for "DNA adduct formation"
DNA adduct formation
Publication
Class
Person
Publication
Programmes
publication
CYP1A1/2 and prostaglandin H synthase catalyze reductive activation of inflammatory drug aristolochic acid and that results in DNA adduct formation
2000 |
First Faculty of Medicine, Faculty of Mathematics and Physics
publication
Peroxidase-mediated ellipticine-DNA adduct formation explains the selective efficiency of this anticancer drug against breast cancer and leukemia
2003 |
Faculty of Science
publication
DNA adduct formation by carcinogenic chemicals and their determination by the 32P-postlabelling technique.
1999 |
First Faculty of Medicine, Faculty of Mathematics and Physics
publication
Ellipticine oxidation and DNA adduct formation in human hepatocytes is catalyzed by human cytochromes P450 and enhanced by cytochrome b5
2012 |
Faculty of Science
publication
The influence of ochratoxin A on DNA adduct formation by the carcinogen aristolochic acid in rats
2015 |
Faculty of Science
publication
DNA adduct formation from quaternary benzo[c]phenanthridine alkaloids sanguinarine and chelerythrine as revealed by the 32P-postlabeling technique
2002 |
Faculty of Science
publication
DNA adduct formation from quaternary benzo[c]phenanthridine alkaloids sanguinarine and chelerythrine as revealed by the 32P-postlabeling technique
2002 |
First Faculty of Medicine, Faculty of Mathematics and Physics
publication
The effect of pH on peroxidase-mediated oxidation of and DNA adduct formation by ellipticine
2006 |
Faculty of Science
publication
Covalent DNA Adduct Formation Mediated by Cytochromes 450
2004 |
Faculty of Science
publication
Covalent DNA Adduct Formation Mediated by Cytochromes 450
2004 |
First Faculty of Medicine, Faculty of Mathematics and Physics
publication
Impact of genetic modulation of SULT1A enzymes on DNA adduct formation by aristolochic acids and 3-nitrobenzanthrone
2017 |
Faculty of Science
publication
Co-Exposure to Aristolochic Acids I and II Increases DNA Adduct Formation Responsible for Aristolochic Acid I-Mediated Carcinogenicity in Rats
2021 |
Faculty of Science
publication
DNA adduct formation by carcinogenic chemicals and their determination by the 32P-postlabelling technique.
1999 |
Faculty of Science
publication
DNA adduct formation by the anticancer drug ellipticine in rats determined by 32P-postlabeling
2003 |
Faculty of Science
publication
DNA adduct formation by the anticancer drug ellipticine in rats determined by 32P-postlabeling
2003 |
First Faculty of Medicine, Faculty of Mathematics and Physics
publication
Mutagenicity and DNA adduct formation of PAH, nitro-PAH, and oxy-PAH fractions of atmospheric particulate matter from Sao Paulo, Brazil
2008 |
Faculty of Science
publication
2-Anisidine is a genotoxic carcinogen: evidence for 2-anisidine-DNA adduct formation in vitro a in vivo
2003 |
Faculty of Science
publication
Cytotoxicity of and DNA adduct formation by ellipticine in human U87MG glioblastoma cancer cells
2009 |
Faculty of Science, First Faculty of Medicine, Faculty of Mathematics and Physics
publication
2-Anisidine is a genotoxic carcinogen: evidence for 2-anisidine-DNA adduct formation in vitro a in vivo
2003 |
First Faculty of Medicine, Faculty of Mathematics and Physics
publication
Evidence for activation of carcinogenic o-anisidine by prostaglandin H synthase: 32P-postlabeling analysis of DNA adduct formation
2001 |
Faculty of Science
publication
The mechanism of cytotoxicity and DNA adduct formation by the anticancer drug ellipticine in human neuroblastoma cells
2009 |
Faculty of Science, Faculty of Physical Education and Sport, First Faculty of Medicine
publication
Evidence for activation of carcinogenic o-anisidine by prostaglandin H synthase: 32P-postlabeling analysis of DNA adduct formation
2001 |
First Faculty of Medicine, Faculty of Mathematics and Physics
publication
The mechanism of cytotoxicity and DNA adduct formation by the anticancer drug ellipticine in human neuroblastoma cells
2009 |
Second Faculty of Medicine
publication
Cytotoxicity of and DNA adduct formation by ellipticine and its micellar form in human leukemia cells in vitro
2015 |
Faculty of Science, Second Faculty of Medicine
publication
DNA adduct formation by the anticancer drug ellipticine in human leukemia HL-60 and CCRF-CEM cells
2007 |
Faculty of Science, Second Faculty of Medicine
publication
Mechanism of DNA adduct formation by anticancer drug ellipticine activated by cytochromes P450 in vitro and in vivo
2003 |
Faculty of Science
publication
Carcinogenic and nephrotoxic alkaloids aristolochic acids are activated by D,T-diaphorase: 32P-postlabeling analysis of DNA adduct formation
2001 |
Faculty of Science
publication
Carcinogenic and nephrotoxic alkaloids aristolochic acids are activated by D,T-diaphorase: 32P-postlabeling analysis of DNA adduct formation
2001 |
First Faculty of Medicine, Faculty of Mathematics and Physics
publication
Mechanism of DNA adduct formation by anticancer drug ellipticine activated by cytochromes P450 in vitro and in vivo
2003 |
First Faculty of Medicine, Faculty of Mathematics and Physics
publication
Effect of Hepatic Cytochrome P450 (P450) Oxidoreductase Deficiency on 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine- DNA Adduct Formation in P450 Reductase Conditional Null Mice
2011 |
Faculty of Science